How Viruses Hijack Cells: Infection and Replication Cycle

Viruses are genetic parasites that commandeer cellular machinery to replicate. Understanding their entry, replication, and release strategies underpins antiviral drug design.

The InfoNexus Editorial TeamMay 16, 20269 min read

A Virus Has No Metabolism of Its Own

A free-floating virus particle — a virion — does nothing. It cannot eat, move, or replicate. It carries only genetic material (DNA or RNA) wrapped in a protein coat (capsid), sometimes surrounded by a lipid envelope. Everything it needs to reproduce lives inside a host cell. A single virion entering a cell can exit as 100,000 copies within hours. This ruthless efficiency of molecular piracy is what makes viruses the most abundant biological entities on Earth.

Viral Architecture

Viruses come in two main genome types:

TypeExamplesKey Feature
DNA virusHerpes, pox, adenovirus, hepatitis BMore stable genome; often enters nucleus
+RNA virusSARS-CoV-2, poliovirus, dengueGenome acts directly as mRNA
−RNA virusInfluenza, measles, EbolaMust carry RNA-dependent RNA polymerase
RetrovirusHIV, HTLVRNA→DNA via reverse transcriptase; integrates into host genome
dsRNA virusRotavirus, reovirusDouble-stranded RNA genome

Step 1: Attachment

Infection begins when viral surface proteins bind to specific receptors on the host cell surface. This interaction determines tropism — which cell types a virus can infect. SARS-CoV-2 spike protein binds ACE2 receptors, which are abundant on lung epithelium. HIV gp120 binds CD4 and a co-receptor (CCR5 or CXCR4) on T helper cells. Influenza hemagglutinin binds sialic acid residues on respiratory epithelial cells.

Receptor specificity is a double-edged sword for viruses: it provides precise entry points but limits the host range. When viruses mutate to bind new receptors, they can jump species — zoonotic spillover, as happened with SARS-CoV-2, H5N1, and HIV (originally SIVcpz from chimpanzees).

Step 2: Entry

After attachment, viruses must deliver their genome inside the cell. Several mechanisms exist:

  • Membrane fusion — enveloped viruses (influenza, HIV, SARS-CoV-2) fuse their lipid envelope with the host cell membrane directly or after endocytosis, releasing the capsid into the cytoplasm
  • Endocytosis — the cell engulfs the virus in a vesicle; acidification of the endosome triggers conformational changes that release the viral genome
  • Injection — bacteriophages inject DNA directly into bacteria through a syringe-like mechanism

Step 3: Genome Replication

Inside the cell, the virus redirects cellular resources to copy its genome and make viral proteins. RNA viruses replicate in the cytoplasm using viral RNA-dependent RNA polymerases (RdRp) — enzymes the host cell doesn't have. DNA viruses typically travel to the nucleus to hijack the cell's own DNA polymerase and transcription machinery.

The viral polymerases of RNA viruses lack proofreading capability. Error rates of ~10⁻⁴ to 10⁻⁶ per base per replication mean RNA viruses mutate rapidly — generating swarms of variants (quasispecies) from a single infecting particle. This is why influenza changes year to year and why HIV develops drug resistance so readily.

Step 4: Protein Synthesis and Assembly

Viral mRNAs are translated by the host cell's ribosomes. The virus often produces non-structural proteins first (needed for replication) and structural proteins later (capsid, envelope glycoproteins). Newly synthesized genomes and structural proteins self-assemble into progeny virions — a process governed by geometry and protein-protein interactions rather than enzymatic machinery.

  • Icosahedral capsids (adenovirus, poliovirus) — 20-sided symmetry, maximum volume with minimum protein
  • Helical capsids (tobacco mosaic virus, Ebola) — proteins spiral around the genome
  • Complex architecture (poxviruses, bacteriophages) — multiple layers, specialized structures

Step 5: Release

Viruses exit cells by two main routes:

  • Lysis — non-enveloped viruses (poliovirus, adenovirus) burst the cell, releasing thousands of virions simultaneously and killing the host cell
  • Budding — enveloped viruses (influenza, HIV, herpes) bud from the cell membrane, taking a lipid envelope with them; cells may survive longer, chronically producing virus

Antiviral Drug Targets

Drug ClassTarget StepExamples
Receptor blockersAttachmentMaraviroc (blocks CCR5 for HIV)
Fusion inhibitorsEntryEnfuvirtide (HIV)
Polymerase inhibitorsGenome replicationRemdesivir (SARS-CoV-2 RdRp)
Protease inhibitorsProtein processingPaxlovid (nirmatrelvir), HIV PIs
Neuraminidase inhibitorsReleaseOseltamivir (Tamiflu) for influenza

Each step in the viral replication cycle represents a potential drug target. The challenge is selectivity: viruses use so much host cell machinery that hitting the virus without killing the cell requires precise targeting of virus-specific proteins. This is also why most antiviral drugs target specific viruses — unlike broad-spectrum antibiotics, truly broad-spectrum antivirals remain a major unmet goal.

biologyvirologymedicine

Related Articles